Paul Mulholland reports on the recent ISMO Fellowship and Bursary Awards meeting The 2020 Irish Society...

The last decade has seen major advances in oncology therapy with the addition of PARP inhibitors,...

First China-manufactured trastuzumab biosimilar HLX02 global phase 3 trial met primary endpoint in breast cancer outcomes...

Priscilla Lynch reports on the latest data on breast cancer incidence, treatment, and outcomes in Ireland...

Sandra Ryan provides an overview of this year’s Gathering around Cancer Conference, which was held in...

Next month, the seventh Gathering Around Cancer conference takes place in Croke Park, Dublin. David Lynch...

Priscilla Lynch presents a round-up of the most important studies presented at the 2019 American Society...

No improvement in disease-free survival (DFS) with adjuvant pazopanib (a VEGF tyrosine kinase inhibitor) was observed...

Dr Dearbhaile Collins outlines the latest trial data on immunotherapies for cervical cancer The National Cancer...

The introduction of robotic surgery in GUH is a major benefit for prostate patients, writes Mr...